Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics
L Pekarek, MJ Garrido‑Gil… - Oncology …, 2023 - spandidos-publications.com
Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity
and accounts for> 90% of all oral cancers. Despite advances in diagnostic procedures and …
and accounts for> 90% of all oral cancers. Despite advances in diagnostic procedures and …
Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer
Due to the heterogeneity of colon cancer, surgery, chemotherapy, and radiation are
ineffective in all cases. The genomic profile and biomarkers associated with the process are …
ineffective in all cases. The genomic profile and biomarkers associated with the process are …
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: prevailing insights on molecular pathways, diagnosis, and nanomedicine …
Head and neck squamous cell carcinoma is a disease that most commonly produce tumours
from the lining of the epithelial cells of the lips, larynx, nasopharynx, mouth, or oro-pharynx. It …
from the lining of the epithelial cells of the lips, larynx, nasopharynx, mouth, or oro-pharynx. It …
Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review
M Zhu, Y Sun, H Bai, Y Wang, B Yang… - Frontiers in …, 2023 - frontiersin.org
Cancer poses a serious threat to human health, and the search for safe and effective drugs
for its treatment has aroused interest and become a long-term goal. Traditional Chinese …
for its treatment has aroused interest and become a long-term goal. Traditional Chinese …
[HTML][HTML] Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy
LR Fang, YH Wang, ZZ Xiong, YM Wang - OpenNano, 2023 - Elsevier
Cancer continues to threaten people's lives and health, and the number of deaths from
cancer is very high each year. Traditional treatments such as chemotherapy and surgery are …
cancer is very high each year. Traditional treatments such as chemotherapy and surgery are …
Platelet membrane-based biochemotactic-targeting nanoplatform combining PDT with EGFR inhibition therapy for the treatment of breast cancer
G Wan, X Chen, R Gou, C Guan, J Chen, Q Wang… - Biomaterials …, 2024 - pubs.rsc.org
Presently, the commonly used anti-tumor drugs lack targeting ability, resulting in a limited
therapeutic efficacy and significant side effects. In this view, platelet membranes (PMs) not …
therapeutic efficacy and significant side effects. In this view, platelet membranes (PMs) not …
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents
D Nasser Binjawhar, FA Al-Salmi, MA Alghamdi… - ACS …, 2024 - ACS Publications
A new series of cinnamide-fluorinated derivatives has been synthesized and characterized
by using different spectroscopic and elemental microanalyses methods. All of the prepared p …
by using different spectroscopic and elemental microanalyses methods. All of the prepared p …
Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer
CHDP Diniz, T Henrique, ACB Stefanini… - Oncology …, 2024 - spandidos-publications.com
The complex evolution of genetic alterations in cancer that occurs in vivo is a selective
process involving numerous factors and mechanisms. Chemotherapeutic agents that …
process involving numerous factors and mechanisms. Chemotherapeutic agents that …
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co‐targeting EGFR and PI3K in cisplatin‐resistant HNSCC
Purpose To find a new strategy to treat cisplatin‐resistant head and neck squamous cell
carcinoma (HNSCC), we investigated the effects of EGFR inhibitors on the PI3K/Akt/mTOR …
carcinoma (HNSCC), we investigated the effects of EGFR inhibitors on the PI3K/Akt/mTOR …
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell …
KM Burcher, CH Bloomer, E Gavrila… - Therapeutic …, 2024 - journals.sagepub.com
Background: Immunotherapy with programmed death receptor-1 (PD-1) inhibitors, as a
single agent or in combination with chemotherapy, is the standard first-line treatment for …
single agent or in combination with chemotherapy, is the standard first-line treatment for …